What is the role of the NSS-2 Bridge device in the treatment of opioid withdrawal?

Updated: Mar 23, 2020
  • Author: David W Dixon, DO; Chief Editor: Glen L Xiong, MD  more...
  • Print

In 2017, the FDA approved the first device designed to reduce the symptoms of opioid withdrawal. The NSS-2 Bridge device is placed behind the patient's ear and emits electrical pulses to stimulate branches of certain cranial nerves. The device can be used for up to 5 days during the acute phase of opioid withdrawal. Approval was based on a single-arm study of 73 patients undergoing physical withdrawal from opioids. Within 30 minutes of using the device, all patients showed a reduction in Clinical Opiate Withdrawal Scale (COWS) score of almost 31%. The device is available by prescription only. [69]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!